Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031240346Active, not recruiting
Trial of cysteamine in cystinosis (2 arms), sponsored by International Medical Research and Development Fund. Primary endpoint: Pharmacokinetic parameters of cysteamine. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031240346.